AzTrials
AzTrials

AbortionVTOPSimpactNCT05688228

Voluntary Interruption of Pregnancy on Women's Sexuality

An observational study of Abortion, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The impact on sexuality has been less studied and there is no French study on this subject and the rare studies are contradictory. The aim of this study is to evaluate the impact of abortion (medical or surgical) on female sexuality, to look for a difference in the impact on sexuality according to the method used for… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Abortion
What is being tested?
questionnaire
How many people
209 participants
Where
1 siteFrance
Study dates
27 Feb 2023to 10 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Women performing a medical or surgical abortion

Who may be able to join

  • Adult patient (≥ 18 years)
  • Patient performing a medical or surgical abortion
  • Patient with health insurance
  • No opposition to participation in the study

Who cannot join

  • Patient who does not speak French and/or is illiterate
  • Patient under legal protection
  • Patient unable to complete the study procedures (no internet connection, no smart phone or tablet)
  • Patient with diagnosed psychiatric comorbidities.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Bordeaux

    Bordeaux

Other trials in France

About this study

Official title: Description of the Evolution of Women's Sexuality After a Voluntary Interruption of Pregnancy

The impact on sexuality has been less studied and there is no French study on this subject and the rare studies are contradictory.

The aim of this study is to evaluate the impact of abortion (medical or surgical) on female sexuality, to look for a difference in the impact on sexuality according to the method used for the termination (medical or surgical) just after the procedure and at 1, 3 and 6 months and to look for risk factors and protective factors for the existence or occurrence of sexual dysfunction before and after abortion.

Read the detailed description

The medical consequences of abortion are low. However, there is an undeniable emotional and psychological impact on these women (40-45% of anxiety-type symptoms, approximately 20% of depressive symptoms after the discovery of the pregnancy and 30% of emotional disorders, particularly anxiety, in the month following the abortion).

The impact on sexuality has been less studied and there is no French study on this subject and the rare studies are contradictory.

The aim of this study is to evaluate the impact of voluntary termination of pregnancy (medical or surgical) on female sexuality, to look for a difference in the impact on sexuality according to the method used for the termination (medical or surgical) just after the procedure and at 1, 3 and 6 months and to look for risk factors and protective factors for the existence or occurrence of sexual dysfunction before and after a termination.

Conditions
Abortion
Being tested
questionnaire
Keywords
Abortion, Female sexuality, FSFI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • questionnaireOther

    Female Sexual Function Index (FSFI) and self-administrative questionnaires on sexuality just after abortion and repeated at 1, 3 and 6 months

Study groups in NCT05688228
Study groupRoleWhat they receive
AbortionAdult women performing a medical or surgical abortion
Receives: Other: questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with sexual dysfunction

    Sexual dysfunction is assessed using the Female Sexual Function Index (FSFI) questionnaire, which takes into account several aspects of female sexuality: desire, arousal, lubrication, orgasm, satisfaction and pain. The threshold for differentiating between patients with and without sexual dysfunction is 26.55

    Measured: Month 6

Secondary outcomes (13)
  1. Marital status

    single, couple, married

    Measured: Baseline

  2. Number of sexual partners in the last 12 months

    Number of sexual partners via self-questionnaire : 1 ; from 2 to 5 ; from 6 to 10 ; from 11 to 15 ; from 16 to 20 ; up to 20

    Measured: Baseline

  3. Number of sexual partners in the whole life

    Number of sexual partners via self-questionnaire : 1 ; from 2 to 5 ; from 6 to 10 ; from 11 to 15 ; from 16 to 20 ; up to 20

    Measured: Baseline

  4. Number of sexual partners in the last 4 weeks

    Number of sexual partners via self-questionnaire : 0, 1, from 2 to 5, up to 5

    Measured: Baseline

  5. Frequency of sexual activity in the last month before pregnancy discovery

    < 1 /month ; from 1 from 3 /month ; 1 /week ; twice /week ; 3 or more times /week

    Measured: Baseline, Month 1, Month 3, Month 6

  6. Existence of physical violence in the whole life

    binary variable (yes/no)

    Measured: Baseline

  7. Existence of psychological violence in the whole life

    binary variable (yes/no)

    Measured: Baseline

  8. Existence of sexual violence in the whole life

    binary variable (yes/no)

    Measured: Baseline

  9. Existence of psychological symptoms before pregnancy's discovery

    asthenia, sadness, anxiety, guilt, none

    Measured: Baseline

  10. Existence of psychological symptoms in the last month

    asthenia, sadness, anxiety, guilt, none

    Measured: Month 1, Month 3, Month 6

  11. Existence of sexual difficulties since pregnancy's discovery

    Decreased desire, arousal, lubrication, quantity or quality of orgasms, sexual satisfaction or relationship with the partner, appearance or increase of pain during sexual intercourse, no change in these different areas of sexuality

    Measured: Baseline

  12. Sexual activity the last month

    Decreased sexual activity (fear of another pregnancy, waiting to start contraception, conflict with partner after abortion, other reason), Not concerned about decreased sexual activity

    Measured: Month 1, Month 3, Month 6

  13. Contraception in the last month

    none, removal/cycles, condoms, pill, intrauterine devic, implant, ring/patch, other

    Measured: Month 1, Month 3, Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2023
  2. Study start27 Feb 2023
  3. Primary completion10 Feb 2024
  4. Study completion10 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
209 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05688228
Sponsor's protocol ID
CHUBX 2022/71
Acronym
VTOPSimpact
Status last verified
May 2024
First submitted
28 Dec 2022
Last updated
8 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Abortion, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with sexual dysfunction (time frame: Month 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in